Osmotic self-expanding dilation technology for treatment of sinusitis: the Vent-Os sinus dilation system

Abstract

The Vent-Os Sinus Dilation System is an osmotically driven device that provides a means to access the sinus space and to dilate the maxillary sinus ostia and associated spaces in adults for diagnostic and therapeutic procedures. Unlike balloon dilation devices that use rapid, high-pressure inflation, this self-expanding device is designed to gently and gradually open the maxillary ostia. The procedure can be safely and easily completed in-office with minimal anesthetics and analgesics on board. Clinical results support excellent patency and safety outcomes with the use of this product in patients with chronic rhinosinusitis.

Keywords:

• chronic rhinosinusitis
• sinuplasty
• sinus ostia dilation
• sinusitis

Financial & competing interests disclosure

P Catalano is a consultant for SinuSys Corp; J Hester is the Medical Director of SinuSys Corp; E Mandrusov is an employee for SinuSys Corp. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Key issues

• Treatment paradigm to address patients with chronic rhinosinusitis in need of sinus opening has been changing over the past 10 years from functional endoscopic sinus surgery to less invasive sinuplasty procedures.

• Sinuplasty procedures can now be completed in an in-office setting, enabling faster patient recovery time without sacrificing efficacy of treatment.

• Sinuplasty products are becoming easier, less cumbersome to use for the physicians and less traumatic to the patient.

• Sinuplasty procedures should be considered for patients more upstream in the disease progression to minimize extensive use of steroids and antibiotics to manage the condition.

• The Vent-Os system uses a low-pressure osmotic dilation technology to address chronic maxillary sinus disease, and has been shown to be safe, and equally effective to other sinuplasty technologies currently available.